International Patent: ANTI-CDCP1 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, ANTIBODY-DRUG CONJUGATE COMPRISING THE SAME, AND USES THEREOF

GENEVA, July 18 -- AIMED BIO INC. filed a patent application (KR2026/000529) for “ANTI-CDCP1 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, ANTIBODY-DRUG CONJUGATE COMPRISING THE SAME, AND USES THEREOF”. With publication no. WO/2026/151284, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 47/68

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....